All In Biotech

Drug Trial Radar · NCT00236015

A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder

A 10-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Gabitril at 4, 8, and 12 mg/Day in the Treatment of Adults With Generalized Anxiety Disorder.

Last checked: Nov 19, 2026Latest source record: May 9, 2014 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 880 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

880

Actual

Start

Nov 2004

Primary completion

Not stated

Study completion Mar 2006

Sponsor

Lead sponsor
CephalonIndustry
Sponsor type
Industry
First posted
Oct 12, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Who can join
All sexes, from 18 years, up to 64 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the safety and efficacy of an investigational anti-anxiety medication relative to placebo in patients with generalized anxiety disorder (GAD).

Conditions

  • Anxiety Disorder

Interventions

  • GabitrilDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Reduction of symptomatology associated with Generalized Anxiety Disorder as assessed by the change from baseline to end point in the total score of the HAM-A scale.

Locations

54 sites in 2 countries. Site status is shown where the registry gives one.

  • Pivotol Research Centers

    Mesa, Arizona

  • Pivotal Research Center

    Peoria, Arizona

  • Valley Clinical Research

    El Centro, California

  • Radiant Research Irvine

    Irvine, California

  • Pharmacology Research Institute

    Los Alamitos, California

  • Pharmacology Research Institute

    Riverside, California

  • Clinical Innovations, Inc.

    Santa Ana, California

  • Radiant Research

    Denver, Colorado

  • University of Connecticut Health Center

    Farmington, Connecticut

  • Miami Research Associates

    Miami, Florida

  • Medical Research Group of Central Florida

    Orange City, Florida

  • Clinical Neuroscience Solutions, Inc.

    Orlando, Florida

  • Roskamp Institute, Clinical Trials Division

    Sarasota, Florida

  • Stedman Clinical Trials

    Tampa, Florida

  • Emory University

    Atlanta, Georgia

  • American Medical Research

    Aurora, Illinois

  • Henry Lahmeyer MD & Associates

    Northfield, Illinois

  • Midwest Center for Neurobehavioral Medicine

    Oakbrook Terrace, Illinois

  • Indiana University Hospital AOC

    Indianapolis, Indiana

  • Vince & Associates Clinical Research

    Overland Park, Kansas

  • Pedia Research, LLC

    Owensboro, Kentucky

  • Four Rivers Clinical Research

    Paducah, Kentucky

  • LSU Health Science Center

    Shreveport, Louisiana

  • Capital Clinical Research Associates

    Rockville, Maryland

  • Dupont Clinical Research

    Rockville, Maryland

  • Center for Psychopharmacologic Research and Treatment

    Worcester, Massachusetts

  • Wayne State University

    Detroit, Michigan

  • Regions Hospital - Department of Behavioral Health

    Saint Paul, Minnesota

  • Radiant Research

    Las Vegas, Nevada

  • Center for Emotional Fitness

    Moorestown, New Jersey

  • Fieve Clinical Services, Inc.

    New York, New York

  • Behavioral Medical Research of Staten Island

    Staten Island, New York

  • Medark Clinical Trials and Research

    Morganton, North Carolina

  • Richard Weisler, MD and Associates

    Raleigh, North Carolina

  • Wake Research Associates, LLC

    Raleigh, North Carolina

  • Midwest Clinical Research Center

    Dayton, Ohio

  • Pahl Pharmaceutical Research, LLC

    Oklahoma City, Oklahoma

  • Oregon Center for Clinical Investigations, Inc.

    Eugene, Oregon

  • Keystone Clinical Studies, LLC

    Norristown, Pennsylvania

  • CNS Research Institute

    Philadelphia, Pennsylvania

Showing 40 of 54 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.